when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News

Hubs

Topics
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

Neurology · news · pharmadog

← back to Neurology

News · Neurology

173 stories

May 11, 26ctDNA in Metastatic Urothelial Carcinomaonclive

May 11, 26Institutional Perspectives on Treatment Thresholds in PLGGonclive

May 11, 26Renal Cell Carcinoma: Practical Treatment Selection Across Risk Groupsonclive

May 11, 26The connection between periods and mental healthstat

May 10, 26Five Under 5: Top Oncology Videos for the Week of 5/3onclive

May 9, 26ADCs Reshape the Future of Lung Cancer Care: From Second-Line Therapy to Earlier Interventiononclive

May 9, 26The OncFive: Top Oncology Articles for the Week of 5/3onclive

May 8, 26Dr Randall on Long-Term Responses and Functional Benefits With Pimicotinib in TGCTonclive

May 8, 26Post–T-DXd Sacituzumab Govitecan Plus Trastuzumab Yields Low ORR in HER2+ Metastatic Breast Canceronclive

May 8, 26Dr Sznol on the Nuances of Recommending Neoadjuvant Therapy in Metastatic Melanomaonclive

May 8, 26Biomarker-Directed Therapies Move the GI Oncology Paradigm Beyond a One-Size-Fits-All Approach: With Michael J. Pishvaian, MD, PhDonclive

May 8, 26Capivasertib/Fulvestrant Yields Numerical OS Advantage in PIK3CA/AKT1/PTEN–Altered Breast Canceronclive

May 8, 26FDA Approves Zenocutuzumab for NRG1 Fusion+ Cholangiocarcinomaonclive

May 8, 26UT MD Anderson Shares Latest Research Breakthroughsonclive

May 8, 26Giants of Cancer Care Announces the 14th Annual Class of Inducteesonclive

May 8, 26OncLive Weekly News Quiz (5/8/2026): Test Your Knowledge on Key Breast, Lung, and Pancreatic Cancer Updatesonclive

May 8, 26OncLive Polls Reveal Picks for Top Lung Cancer Abstracts at ASCO 2026onclive

May 8, 26Poll Results Highlight Breast Cancer Abstracts of Interest at ASCO 2026onclive

May 8, 26Lilly, Gilead lead pharma’s M&A boombiopharma dive

May 8, 26Dr Gruenbaum on Where Alternative Options to BTK Inhibitors Stand in MCLonclive

May 7, 26Angelini to buy Catalyst in $4B play for rare neuro drugsbiopharma dive

May 7, 26Track the Lung Cancer Abstracts That are Gaining Attention at ASCO 2026onclive

May 7, 26Reigniting Your Curiosity During Fellowshiponclive

May 7, 26Angelini fortifies neurology portfolio with $4.1B buyout of Catalystendpoints

May 7, 26STAT+: Angelini Pharma buys Catalyst Pharmaceuticals and its rare disease drugs for $4.1Bstat

May 6, 26Dr Chari on Frontline Combinations and Transplant Approaches in Multiple Myelomaonclive

May 6, 26Cases and Conversations™: Next-Generation Pathology Advances and Considerations for Precision Care in Non–Small Cell Lung Canceronclive

May 6, 26Dr Herrera on the Significance of the FDA Approval of Nivolumab Plus AVD for Classical Hodgkin Lymphomaonclive

May 6, 26Dr Sznol on Biomarkers of Response in Metastatic Melanomaonclive

May 6, 26Transformational Utah Investment in Artificial Intelligence and Computing to Advance Health and Discoveryonclive

← prevpage 5 of 6next →